20 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/20/2901566/0/en/atai-Life-Sciences-Announces-Update-on-Beckley-Psytech-s-Phase-1-2a-Trial-of-ELE-101-IV-Psilocin-for-Major-Depressive-Disorder-with-Initial-Results-from-Phase-1-and-First-Patients-.html
14 May 2024
// BUSINESSWIRE
29 Nov 2023
// PRESS RELEASE
https://phytonbiotech.com/phyton-controlled-substances-dealers-license-health-canada/
29 Oct 2023
// PRESS RELEASE
https://phytonbiotech.com/phyton-controlled-substances-dealers-license-health-canada/
24 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/terran-biosciences-announces-publication-of-pct-patent-application-covering-novel-orally-active-forms-of-psilocin-with-improved-pharmacokinetic-properties-301755108.html
12 Aug 2022
// ACCESSWIRE
https://www.accesswire.com/711998/Core-One-Labs-Subsidiaries-Successfully-Produce-Psilocin-Precursor-for-Production-to-Psilocybin
LOOKING FOR A SUPPLIER?